Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Metabolites|October 27, 2022
Performance Verification of CYP2C19 Enzyme Abundance Polymorphism Settings within the Simcyp Simulator v21Caroline Sychterz, Iain Gardner, Manting Chiang, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 26, 2024
Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy ParticipantsSamira Merali, Manting Chiang, Caroline Sychterz, et al.Clinical Pharmacology and Therapeutics|October 8, 2025
Application of Physiologically Based Pharmacokinetic Modeling to Inform Dose Selection of Mezigdomide in a Phase I Drug-Drug Interaction StudyJoseph Burnett, Caroline Sychterz, Jessica Katz, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 8, 2011
Investigations of hydrazine cleavage of eltrombopag in humansYanli Deng, Martin Rogers, Caroline Sychterz, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 4, 2013
Bioavailability, metabolism and disposition of oral pazopanib in patients with advanced cancerYanli Deng, Caroline Sychterz, A Benjamin Suttle, et al.Investigative Ophthalmology & Visual Science|February 7, 2013
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular diseaseScott J Robbie, Peter Lundh von Leithner, Meihua Ju, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 5, 2016
Single ocular injection of a sustained-release anti-VEGF delivers 6months pharmacokinetics and efficacy in a primate laser CNV modelPeter Adamson, Thomas Wilde, Eric Dobrzynski, et al.Pageof 2